1. Home
  2. SPRY vs CRI Comparison

SPRY vs CRI Comparison

Compare SPRY & CRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • CRI
  • Stock Information
  • Founded
  • SPRY 2015
  • CRI 1865
  • Country
  • SPRY United States
  • CRI United States
  • Employees
  • SPRY 160
  • CRI N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • CRI Apparel
  • Sector
  • SPRY Health Care
  • CRI Consumer Discretionary
  • Exchange
  • SPRY Nasdaq
  • CRI Nasdaq
  • Market Cap
  • SPRY 1.4B
  • CRI 1.3B
  • IPO Year
  • SPRY N/A
  • CRI 2003
  • Fundamental
  • Price
  • SPRY $13.44
  • CRI $34.14
  • Analyst Decision
  • SPRY Strong Buy
  • CRI Sell
  • Analyst Count
  • SPRY 4
  • CRI 5
  • Target Price
  • SPRY $28.75
  • CRI $36.20
  • AVG Volume (30 Days)
  • SPRY 1.2M
  • CRI 1.6M
  • Earning Date
  • SPRY 05-14-2025
  • CRI 04-25-2025
  • Dividend Yield
  • SPRY N/A
  • CRI 9.37%
  • EPS Growth
  • SPRY N/A
  • CRI N/A
  • EPS
  • SPRY 0.08
  • CRI 4.51
  • Revenue
  • SPRY $89,149,000.00
  • CRI $2,812,437,000.00
  • Revenue This Year
  • SPRY $1.49
  • CRI N/A
  • Revenue Next Year
  • SPRY $141.68
  • CRI N/A
  • P/E Ratio
  • SPRY $168.00
  • CRI $7.57
  • Revenue Growth
  • SPRY 297063.34
  • CRI N/A
  • 52 Week Low
  • SPRY $7.55
  • CRI $32.04
  • 52 Week High
  • SPRY $18.51
  • CRI $72.11
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 46.69
  • CRI 44.12
  • Support Level
  • SPRY $13.06
  • CRI $32.42
  • Resistance Level
  • SPRY $15.06
  • CRI $34.98
  • Average True Range (ATR)
  • SPRY 0.67
  • CRI 1.57
  • MACD
  • SPRY -0.18
  • CRI 0.18
  • Stochastic Oscillator
  • SPRY 15.97
  • CRI 29.37

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

Share on Social Networks: